ID   UT-SCC-110B
AC   CVCL_A091
SY   University of Turku-Squamous Cell Carcinoma-110B
DR   Cosmic; 1140779
DR   Cosmic; 1219863
DR   Wikidata; Q54992057
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Deep exome analysis.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D19S433: 14,16
ST   D21S11: 30,31.2
ST   D2S1338: 20,26
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 11,14
ST   FGA: 20,21
ST   TH01: 8
ST   TPOX: 8,10,11
ST   vWA: 16,17
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7EB ! UT-SCC-110A
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
RX   DOI=10.1158/1538-7445.AM2020-507;
RA   Kondratyev M.K., Pesic A., Dvorkin-Sheva A., Ketela T., Moffat J.,
RA   Koritzinsky M., Wouters B.G.;
RT   "Repurposing of FDA approved drugs for treatment of metastatic HNSCC.";
RL   Cancer Res. 80 Suppl. 16:507-507(2020).
//
RX   PubMed=30135316; DOI=10.1172/jci.insight.122204; PMCID=PMC6141174;
RA   Jamieson S.M.F., Tsai P., Kondratyev M.K., Budhani P., Liu A.,
RA   Senzer N.N., Chiorean E.G., Jalal S.I., Nemunaitis J.J., Kee D.,
RA   Shome A., Wong W.W., Li D., Poonawala-Lohani N., Kakadia P.M.,
RA   Knowlton N.S., Lynch C.R.H., Hong C.R., Lee T.W., Grenman R.,
RA   Caporiccio L., McKee T.D., Zaidi M., Butt S., Macann A.M.J.,
RA   McIvor N.P., Chaplin J.M., Hicks K.O., Bohlander S.K., Wouters B.G.,
RA   Hart C.P., Print C.G., Wilson W.R., Curran M.A., Hunter F.W.;
RT   "Evofosfamide for the treatment of human papillomavirus-negative head
RT   and neck squamous cell carcinoma.";
RL   JCI Insight 3:e122204.1-e122204.19(2018).
//